Literature DB >> 33344356

Sorafenib Induced Hand-Foot Skin Reaction at Low Dose.

Vrutika H Shah1, Bhagyashree B Supekar2, Rajesh P Singh2, Jayesh I Mukhi2.   

Abstract

Entities:  

Year:  2020        PMID： 33344356      PMCID： PMC7734987          DOI： 10.4103/idoj.IDOJ_115_20

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN： 2229-5178


× No keyword cloud information.
  14 in total

1.  Drug therapy: sorafenib.

Authors:  Richard S Finn
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

2.  Keratoacanthomas associated with sorafenib therapy.

Authors:  Heidi H Kong; Edward W Cowen; Nilofer S Azad; William Dahut; Martin Gutierrez; Maria L Turner
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

3.  Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib.

Authors:  Nancy M Chung; Martin Gutierrez; Maria L Turner
Journal:  Arch Dermatol       Date:  2006-11

4.  Skin toxicities of targeted therapies.

Authors:  Siegfried Segaert; Gabriela Chiritescu; Liesbeth Lemmens; Kristien Dumon; Eric Van Cutsem; Sabine Tejpar
Journal:  Eur J Cancer       Date:  2009-09       Impact factor: 9.162

5.  Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.

Authors:  Julien Autier; Bernard Escudier; Janine Wechsler; Alain Spatz; Caroline Robert
Journal:  Arch Dermatol       Date:  2008-07

6.  Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.

Authors:  W J Lee; J L Lee; S E Chang; M W Lee; Y K Kang; J H Choi; K C Moon; J K Koh
Journal:  Br J Dermatol       Date:  2009-05-05       Impact factor: 9.302

7.  Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma.

Authors:  Amrita Sil; Nilay Kanti Das
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

8.  Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: report of a case and literature review of kinase inhibitors and blocking antibodies.

Authors:  Shuchi Bansal; Kabir Sardana; Kishore Singh; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

9.  Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol.

Authors:  Serkan Demirkan; Özgür Gündüz; Tuba Devrim
Journal:  JAAD Case Rep       Date:  2017-07-20

10.  Effective prevention of sorafenib-induced hand-foot syndrome by dried-bonito broth.

Authors:  Kenya Kamimura; Yoko Shinagawa-Kobayashi; Ryo Goto; Kohei Ogawa; Takeshi Yokoo; Akira Sakamaki; Satoshi Abe; Hiroteru Kamimura; Takeshi Suda; Hiroshi Baba; Takayuki Tanaka; Yoshizu Nozawa; Naoto Koyama; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Yutaka Aoyagi; Shuji Terai
Journal:  Cancer Manag Res       Date:  2018-04-17       Impact factor: 3.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.